URL details: dupixenthcp.com/atopicdermatitis
URL title:
DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis That is Uncontrolled
URL description:
DUPIXENT® (dupilumab) is indicated for the treatment of patients aged 6 mo. & older with uncontrolled moderate-to-severe atopic dermatitis. Serious adverse reactions may occur. Please see Important Safety Information and full PI on website.
URL last crawled:
2022-06-25
URL speed:
0.219 MB/s,
downloaded in 0.300 seconds
We found no external links pointing to this url.